Trastuzumab emtansine in breast cancer

By Dirix Luc Y   Rutten Annemie   Huget Philippe   Dirix Marie  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 607-614

Informa Healthcare

Access to resources Recommend Favorite

A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab

By Rueckert S   Ruehl I   Kahlert S   Konecny G   Untch M  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 853-866

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor

By Simonds Hannah M   Miles David  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 487-491

Informa Healthcare

Access to resources Recommend Favorite

Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer

By Kaklamani Virginia G.   Cianfrocca Mary   Ciccone Jennifer   Kindy Kelly   Rademaker Alfred   Wiley Elizabeth L.   Gradishar William   O’Regan Ruth M.  

Biomarkers, Vol. 15, Iss. 2, 2010-03 ,pp. : 191-193

Informa Healthcare

Access to resources Recommend Favorite

In vivo behaviour of antibody–drug conjugates for the targeted treatment of cancer

By Xie Hongsheng   Blättler Walter A  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 281-291

Informa Healthcare

Access to resources Recommend Favorite